(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of 11.4% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 48.98%.
Biodesix's revenue in 2025 is $74,463,000.On average, 2 Wall Street analysts forecast BDSX's revenue for 2025 to be $12,157,403,421, with the lowest BDSX revenue forecast at $12,150,075,270, and the highest BDSX revenue forecast at $12,164,731,573.
In 2026, BDSX is forecast to generate $15,279,195,982 in revenue, with the lowest revenue forecast at $14,729,584,616 and the highest revenue forecast at $15,828,807,348.